about
Generalized portrait of cancer metabolic pathways inferred from a list of genes overexpressed in cancerFT-IR microspectrometry reveals the variation of membrane polarizability due to epigenomic effect on epithelial ovarian cancerA Cell-Surface Membrane Protein Signature for Glioblastoma.Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models.Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples.A phylogenetic model for understanding the effect of gene duplication on cancer progressionRegPhos 2.0: an updated resource to explore protein kinase-substrate phosphorylation networks in mammals.Divide and conquer: subproteomic approaches toward gastric cancer biomarker and drug target discovery.Mining heterogeneous causal effects for personalized cancer treatment.Aptamer TY04 inhibits the growth of multiple myeloma cells via cell cycle arrest.Cell membrane-derived nanomaterials for biomedical applications.Targeted-TERS detection of integrin receptors on human cancer cells.Mass spectrometry based proteomics for absolute quantification of proteins from tumor cells.General principles of binding between cell surface receptors and multi-specific ligands: A computational study.Luminescence switch-on detection of protein tyrosine kinase-7 using a G-quadruplex-selective probe.Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein.Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns.Prostate-Specific Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Influences In Vivo Side Effects of Doxorubicin.Targeting Tumor-Associated Exosomes with Integrin-Binding Peptides
P2860
Q34176623-2D57FD28-2AB7-4ED6-8671-F6C7CD75111DQ34486707-F67571EF-E10D-44DF-B999-EF8A46E0F006Q34554512-5045F57E-A84B-4235-B282-B7C63730C540Q36111439-A91F18BB-DC3F-49F4-8124-EF44D3893FECQ36351953-D04FB4B9-E905-47B1-8039-26C4FF75ECCDQ37631856-EB5A9828-DBE0-4F18-B5A7-3C69328AF0BEQ37723706-A364CE35-DF68-4B2E-9CEB-50F52207CFC3Q38200653-940C88A5-A004-4F23-99A7-B3ED85E9A085Q38860413-2B5AC7C1-85C0-4731-99E0-BE979A55A7F1Q38998989-EE3B010F-8AA0-42EC-BF82-04721C6C3FE9Q39178313-D4EB905C-5D99-4864-9150-93D72AC0DA40Q41335542-9031BBB7-AD06-4DEA-8329-EFF656389275Q42111836-2FA925B6-78F7-48D7-943D-F0BE60BEE770Q45737672-F76147D7-CA61-4FD6-865C-90947C6056E4Q47140507-DB11FCAB-E71E-485C-B31F-FF74FB20948FQ47700711-11BECE1C-905E-402F-816D-0CB374E2BAD3Q54777296-AF8CB725-374D-4BFB-B57C-03794A7CCD9EQ55396562-04C33558-F696-497E-BAC7-06DE07AD7262Q56889136-435AD36C-3728-4478-9DE0-466B8ED5B513
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Membrane proteins: the key players of a cancer cell.
@en
Membrane proteins: the key players of a cancer cell.
@nl
type
label
Membrane proteins: the key players of a cancer cell.
@en
Membrane proteins: the key players of a cancer cell.
@nl
prefLabel
Membrane proteins: the key players of a cancer cell.
@en
Membrane proteins: the key players of a cancer cell.
@nl
P2860
P1476
Membrane proteins: the key players of a cancer cell.
@en
P2860
P2888
P356
10.1007/S00232-011-9381-7
P50
P577
2011-07-06T00:00:00Z